(MedPage Today) — Use of the investigational non-opioid analgesic resiniferatoxin appeared to improve pain control in patients with advanced cancer who had intractable pain, though all patients experienced adverse events (AEs), according to an…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/115789
Author :
Publish date : 2025-05-28 18:13:00
Copyright for syndicated content belongs to the linked Source.
